ATE150312T1 - Verabreichungsverfahren von dipalmitoylphosphatidylcholindispersionen - Google Patents

Verabreichungsverfahren von dipalmitoylphosphatidylcholindispersionen

Info

Publication number
ATE150312T1
ATE150312T1 AT92308285T AT92308285T ATE150312T1 AT E150312 T1 ATE150312 T1 AT E150312T1 AT 92308285 T AT92308285 T AT 92308285T AT 92308285 T AT92308285 T AT 92308285T AT E150312 T1 ATE150312 T1 AT E150312T1
Authority
AT
Austria
Prior art keywords
dispersion
lungs
patient
phospholipid
dipalmitoylphosphatidylcholine
Prior art date
Application number
AT92308285T
Other languages
English (en)
Inventor
Craig William Davis
Rodney Gary Snyder
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Application granted granted Critical
Publication of ATE150312T1 publication Critical patent/ATE150312T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0082—Lung surfactant, artificial mucus

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dispersion Chemistry (AREA)
  • Otolaryngology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
AT92308285T 1991-09-19 1992-09-11 Verabreichungsverfahren von dipalmitoylphosphatidylcholindispersionen ATE150312T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB919120005A GB9120005D0 (en) 1991-09-19 1991-09-19 Method of administering phospholipid dispersions

Publications (1)

Publication Number Publication Date
ATE150312T1 true ATE150312T1 (de) 1997-04-15

Family

ID=10701652

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92308285T ATE150312T1 (de) 1991-09-19 1992-09-11 Verabreichungsverfahren von dipalmitoylphosphatidylcholindispersionen

Country Status (19)

Country Link
US (1) US5299566A (de)
EP (1) EP0533410B1 (de)
JP (1) JPH06505505A (de)
KR (1) KR930702006A (de)
AT (1) ATE150312T1 (de)
AU (1) AU2554292A (de)
CA (1) CA2096537C (de)
CZ (1) CZ93593A3 (de)
DE (1) DE69218329T2 (de)
DK (1) DK0533410T3 (de)
ES (1) ES2100296T3 (de)
FI (1) FI932254A7 (de)
GB (1) GB9120005D0 (de)
GR (1) GR3023534T3 (de)
HU (1) HUT64697A (de)
IL (1) IL103216A0 (de)
SK (1) SK51093A3 (de)
WO (1) WO1993005787A1 (de)
ZA (1) ZA927178B (de)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4300880C2 (de) * 1993-01-15 1996-03-21 Draegerwerk Ag Ultraschallvernebler mit Dosiereinheit
JP4484247B2 (ja) * 1995-02-24 2010-06-16 エラン ファーマ インターナショナル，リミティド ナノ粒子分散体を含有するエアロゾル
WO1997029738A1 (en) * 1996-02-16 1997-08-21 The Administrators Of The Tulane Educational Fund Methods and compositions for treating eustachian tube dysfunction by inhalation
US5698537A (en) * 1996-06-18 1997-12-16 Clarion Pharmaceuticals Inc. Method of lowering the viscosity of mucus
US20020017295A1 (en) * 2000-07-07 2002-02-14 Weers Jeffry G. Phospholipid-based powders for inhalation
US6565885B1 (en) 1997-09-29 2003-05-20 Inhale Therapeutic Systems, Inc. Methods of spray drying pharmaceutical compositions
US6946117B1 (en) 1997-09-29 2005-09-20 Nektar Therapeutics Stabilized preparations for use in nebulizers
US20060165606A1 (en) 1997-09-29 2006-07-27 Nektar Therapeutics Pulmonary delivery particles comprising water insoluble or crystalline active agents
US6433040B1 (en) 1997-09-29 2002-08-13 Inhale Therapeutic Systems, Inc. Stabilized bioactive preparations and methods of use
US6309623B1 (en) * 1997-09-29 2001-10-30 Inhale Therapeutic Systems, Inc. Stabilized preparations for use in metered dose inhalers
ES2191355T3 (es) * 1997-12-24 2003-09-01 Britannia Pharmaceuticals Ltd Uso de un tensioactivo para la preparacion de un medicamento para el tratamiento de trastornos del oido medio.
US5883084A (en) * 1998-06-08 1999-03-16 Clarion Pharmaceuticals Inc. Treatment of respiratory diseases utilizing α-tocopheryl-phosphocholine
US20020061281A1 (en) * 1999-07-06 2002-05-23 Osbakken Robert S. Aerosolized anti-infectives, anti-inflammatories, and decongestants for the treatment of sinusitis
US6576224B1 (en) * 1999-07-06 2003-06-10 Sinuspharma, Inc. Aerosolized anti-infectives, anti-inflammatories, and decongestants for the treatment of sinusitis
US6676930B2 (en) 1999-11-28 2004-01-13 Scientific Development And Research, Inc. Composition and method for treatment of otitis media
US6156294A (en) 1999-11-28 2000-12-05 Scientific Development And Research, Inc. Composition and method for treatment of otitis media
DE19957898A1 (de) * 1999-12-01 2001-06-07 Byk Gulden Lomberg Chem Fab Neue Verwendung von Lungensurfactant
US8404217B2 (en) 2000-05-10 2013-03-26 Novartis Ag Formulation for pulmonary administration of antifungal agents, and associated methods of manufacture and use
EP1280520B2 (de) * 2000-05-10 2018-03-21 Novartis AG Pulver auf basis von phospholipiden zur wirkstoffverabreichung
US7871598B1 (en) * 2000-05-10 2011-01-18 Novartis Ag Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
AU2001278864A1 (en) * 2000-06-30 2002-01-30 University Of Cincinnati Peptides with antioxidant and antimicrobial properties
CN1449278A (zh) * 2000-09-01 2003-10-15 马库斯·拉松 具有动态膨胀现象的肺表面活性组合物
RU2189820C1 (ru) * 2001-05-03 2002-09-27 Институт медицинских проблем Севера СО РАМН Способ лечения бронхиальной астмы
ATE508735T1 (de) 2001-12-19 2011-05-15 Novartis Ag Pulmonale verabreichung von aminoglykosiden
US20040055595A1 (en) * 2002-09-19 2004-03-25 Noymer Peter D. Aerosol drug delivery system employing formulation pre-heating
CA2567334A1 (en) * 2004-05-20 2005-12-08 Discovery Laboratories, Inc. Methods , systems and devices for noninvasive pulmonary delivery
US8337815B2 (en) * 2004-12-23 2012-12-25 Discovery Laboratories, Inc. Pulmonary surfactant formulations
US8028697B2 (en) 2005-04-28 2011-10-04 Trudell Medical International Ventilator circuit and method for the use thereof
US20070031342A1 (en) * 2005-06-22 2007-02-08 Nektar Therapeutics Sustained release microparticles for pulmonary delivery
EP2086617A4 (de) * 2006-10-26 2013-11-20 Next Breath Llc Inhalationssystem auf phospholipid-basis
DE102007025898A1 (de) * 2007-06-01 2008-12-04 Matthias W. Dr. Amrein Behandlung von Surfactanten
NZ588478A (en) 2008-03-17 2013-06-28 Discovery Lab Inc Ventilation circuit surrounding proximal aerosol delivery channel
CA2683353C (en) 2008-10-22 2015-12-15 Trudell Medical International Modular aerosol delivery system
CA2805602A1 (en) 2010-08-23 2012-03-01 Takeda Gmbh Humidified particles comprising a therapeutically active substance
US20180050084A1 (en) 2015-02-27 2018-02-22 Board Of Regents, The University Of Texas System Polypeptide therapeutics and uses thereof
JP7496826B2 (ja) 2018-09-10 2024-06-07 ラング セラピューティクス，エルエルシー Ｃａｖ－１タンパク質の修飾ペプチドフラグメント及び線維症の治療におけるその使用
US20220160814A1 (en) 2019-03-11 2022-05-26 Lung Therapeutics, Inc. Compositions and methods for protecting type 2 alveolar epithelial cells (aec2)

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3745991A (en) * 1971-02-22 1973-07-17 Champion Spark Plug Co Environmental contamination control device
DE2729768C3 (de) * 1977-07-01 1981-02-12 Carl Heyer Gmbh, Inhalationstechnik, 5427 Bad Ems Verfahren zur Erzeugung von temperiertem Aerosol für Behandlung von Mensch oder Tier und Vorrichtung zu dessen Durchführung
US4312860A (en) * 1980-10-24 1982-01-26 Regents Of The University Of California Lung surfactant compositions
US4564748A (en) * 1982-10-29 1986-01-14 Respiratory Care, Inc. Variable temperature heating control system for inhalation therapy apparatus
US5038769A (en) * 1983-06-29 1991-08-13 Krauser Robert S Method and apparatus for treating ailments
US4659805A (en) * 1984-12-11 1987-04-21 California Biotechnology, Inc. Recombinant alveolar surfactant protein
US4912038A (en) * 1984-12-11 1990-03-27 California Biotechnology Inc. Recombinant DNA sequence encoding alveolar surfactant protein
US4933280A (en) * 1984-12-11 1990-06-12 California Biotechnology Inc. Recombinant DNA sequence encoding Alveolar Surfactant Protein
US4826821A (en) * 1985-06-26 1989-05-02 The Regents Of The University Of California Lung surfactant compositions
CA1284517C (en) * 1986-03-18 1991-05-28 Norbert William Ellmann Heating unit for inhalation therapy
US5013720A (en) * 1986-05-06 1991-05-07 Abbott Laboratories SAP-6-Val proteins and methods
US5049388A (en) * 1986-11-06 1991-09-17 Research Development Foundation Small particle aerosol liposome and liposome-drug combinations for medical use
US5032585A (en) * 1987-02-17 1991-07-16 Board Of Regents, The University Of Texas System Methods and compositions employing unique mixtures of polar and neutral lipids for surfactant replacement therapy
DE3712598A1 (de) * 1987-04-14 1988-10-27 Siemens Ag Inhalations-anaesthesiegeraet
US5057502A (en) * 1987-06-02 1991-10-15 Walsh William E Composition and topical and systemic treatments of conditions caused by heavy, oily or greasy secretions
US4832012A (en) * 1987-07-08 1989-05-23 Vortran Medical Technology, Inc. Intermittent signal actuated nebulizer
US5134129A (en) * 1989-03-15 1992-07-28 Board Of Regents, The University Of Texas System Methods employing unique mixtures of polar and neutral lipids for surfactant replacement therapy
ATE201880T1 (de) * 1989-07-11 2001-06-15 Genentech Inc Oberflächenaktive zusammensetzungen und verfahren
ATE192930T1 (de) * 1990-10-17 2000-06-15 Liposome Co Inc Synthetische oberflächenaktive agentien auf der lunge

Also Published As

Publication number Publication date
EP0533410A1 (de) 1993-03-24
DE69218329T2 (de) 1997-07-03
WO1993005787A1 (en) 1993-04-01
IL103216A0 (en) 1993-02-21
HUT64697A (en) 1994-02-28
EP0533410B1 (de) 1997-03-19
CA2096537A1 (en) 1993-03-20
CZ93593A3 (en) 1994-02-16
DK0533410T3 (da) 1997-09-08
GR3023534T3 (en) 1997-08-29
AU2554292A (en) 1993-04-27
ES2100296T3 (es) 1997-06-16
KR930702006A (ko) 1993-09-08
HU9301430D0 (en) 1993-09-28
ZA927178B (en) 1994-03-18
GB9120005D0 (en) 1991-11-06
SK51093A3 (en) 1993-10-06
FI932254L (fi) 1993-07-02
CA2096537C (en) 2003-12-30
FI932254A0 (fi) 1993-05-18
DE69218329D1 (de) 1997-04-24
JPH06505505A (ja) 1994-06-23
FI932254A7 (fi) 1993-07-02
US5299566A (en) 1994-04-05

Similar Documents

Publication Publication Date Title
ATE150312T1 (de) Verabreichungsverfahren von dipalmitoylphosphatidylcholindispersionen
CA2295177A1 (en) Drug targeting system, method of its preparation and its use
ES2137948T3 (es) Sistema avanzado de administracion de medicamentos y metodo de tratamiento de trastornos psiquiatricos, neurologicos y otros con carbamacepina.
EP0246715A3 (de) Vorrichtung zur sicheren Verabreichung eines Heilmittels an einen Patienten
ATE221375T1 (de) Formulierungen mit kontrollierter abgabe überzogen mit wässrigen dispersionen von ethylcellulose
WO1994008551A3 (en) Pharmaceutical compositions and methods for treating cold symptoms
PT1098643E (pt) Fenilacetilglutamina fenilacetilisoglutamina e/ou fenilacetato para o tratamento de doencas neoplasicas
US3715432A (en) Submicron aqueous aerosols containing lecithin
AU7316591A (en) Use of 3-guanidinopropionic acid in the treatment and prevention of metabolic disorders
HU213677B (en) Pharmaceutical compositions for preventing and treating tumor diseases, and process for producing them
NO166939C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive carboxylsyrederivater.
IL106785A0 (en) Use of nadh and nadph as drugs for treating alzheimer's disease
MY104006A (en) 4-quinoline carboxylic acid derivatives useful for treating skin and muco-epithelial diseases.
NO880272D0 (no) Fremgangsmaate for fremstilling av heksametylmelaminholdige medisinske preparater.
DE69924483D1 (de) Kombinationstherapie zur behandlung von tumoren
TW263512B (de)
ATE99930T1 (de) Mischung von vitamin a in physiologischer dosis und verschiedenen wirkstoffen mit therapeutischer wirksamkeit.
WO1996020702B1 (en) The use of 2,3-alkylcarbonyloxybenzoic acid in treating adult respiratory distress syndrome
RU95102346A (ru) Способ лечения дисциркуляторной энцефалопатии
Moesgaard-Nielsen et al. Perennial rhinitis treated with a new steroid: fluocortin butylester (FCB)
Diukova et al. Treatment of autonomic crises (attacks of panic)
ATE490780T1 (de) Menschliches wachstumshormon zur behandlung von anorexia nervosa
UA10219A (uk) Спосіб лікування туберкульозу легень

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee